New Covid Vaccine Could Appeal To Some Religious Skeptics
Novavax announced on January 31 that it had submitted a request to the U.S. Food and Drug Administration (FDA) for emergency use authorization for its Nuvaxovid (NVX-CoV2373) COVID-19 vaccine. The company has reported it does not use any human fetal-derived cell lines for Nuvaxovid, which has been a sticking point for many people who object to vaccinations. A December poll by the Public Religion Research Institute and the Interfaith Youth Core found that 10 percent of Americans said they believe getting a COVID-19 vaccines was against their religion, and some people have cited the fetal cells link to vaccines in lawsuits against mandates....